JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling

被引:113
作者
Sporri, B
Kovanen, PE
Sasaki, A
Yoshimura, A
Leonard, WJ [1 ]
机构
[1] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA
[2] Kurume Univ, Inst Life Sci, Kurume, Fukuoka 830, Japan
关键词
D O I
10.1182/blood.V97.1.221
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
JAB/suppressor of cytokine signaling 1 (SOCS1) STAT-induced STAT inhibitor-1 (SSI-1) (JAB/SOCS1/SSI-1) is an SH2-domain-containing protein that is induced by and negatively regulates signaling by a number of cytokines including interleukin-4 (IL-4), IL-6, interferon (IFN)-γ, prolactin, growth hormone, and erythropoietin. The role of JAB/SOCS1/SSI-1 in IL-2 signaling has been analyzed. JAB/SOCS1/SSI-1 is strongly induced by IL-2 in peripheral blood T cells, and JAB/SOCS1/SSI-1 overexpression strongly inhibits IL-2-induced signal transducer and activator of transcription-5 (Stat5) phosphorylation and transcriptional activity. In cotransfection experiments, JAB/SOCS1/SSI-1 associates with both Jak1 and Jak3; however, JAB/SOCS1/SSI-1 had a greater effect on Jak1 tyrosine phosphorylation and kinase activity. JAB/SOCS1/SSI-1 also interacts with IL-2Rβ, and this interaction requires the A region (residues 313-382) of IL-2Rβ. However, this interaction was not essential for the inhibitory action of JAB. Thus, JAB/SOCS1/SSI-1 is an IL-2-induced inhibitor of IL-2 signaling that functions by inhibiting Jak kinase activity. This suggests an important role for JAB/SOCS1/SSI-1 in regulating T-cell responses. © 2001 by The American Society of Hematology.
引用
收藏
页码:221 / 226
页数:6
相关论文
共 55 条
[1]   CIS associates with the interleukin-2 receptor β chain and inhibits interleukin-2-dependent signaling [J].
Aman, MJ ;
Migone, TS ;
Sasaki, A ;
Ascherman, DP ;
Zhu, MH ;
Soldaini, E ;
Imada, K ;
Miyajima, A ;
Yoshimura, A ;
Leonard, WJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (42) :30266-30272
[2]   Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway [J].
Beadling, C ;
Ng, J ;
Babbage, JW ;
Cantrell, DA .
EMBO JOURNAL, 1996, 15 (08) :1902-1913
[3]   PREVENTION OF T-CELL ANERGY BY SIGNALING THROUGH THE GAMMA(C) CHAIN OF THE IL-2 RECEPTOR [J].
BOUSSIOTIS, VA ;
BARBER, DL ;
NAKARAI, T ;
FREEMAN, GJ ;
GRIBBEN, JG ;
BERNSTEIN, GM ;
DANDREA, AD ;
RITZ, J ;
NADLER, LM .
SCIENCE, 1994, 266 (5187) :1039-1042
[4]   Specific inhibition of Stat3 signal transduction by PIAS3 [J].
Chung, CD ;
Liao, JY ;
Liu, B ;
Rao, XP ;
Jay, P ;
Berta, P ;
Shuai, K .
SCIENCE, 1997, 278 (5344) :1803-1805
[5]  
Cohney SJ, 1999, MOL CELL BIOL, V19, P4980
[6]   STATs and gene regulation [J].
Darnell, JE .
SCIENCE, 1997, 277 (5332) :1630-1635
[7]  
De Sepulveda P, 1999, EMBO J, V18, P904
[8]   Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression [J].
Dickensheets, HL ;
Venkataraman, C ;
Schindler, U ;
Donnelly, RP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (19) :10800-10805
[9]   LYMPHOID DEVELOPMENT IN MICE WITH A TARGETED DELETION OF THE INTERLEUKIN-2 RECEPTOR-GAMMA CHAIN [J].
DISANTO, JP ;
MULLER, W ;
GUYGRAND, D ;
FISCHER, A ;
RAJEWSKY, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (02) :377-381
[10]   A new protein containing an SH2 domain that inhibits JAK kinases [J].
Endo, TA ;
Masuhara, M ;
Yokouchi, M ;
Suzuki, R ;
Sakamoto, H ;
Mitsui, K ;
Matsumoto, A ;
Tanimura, S ;
Ohtsubo, M ;
Misawa, H ;
Miyazaki, T ;
Leonor, N ;
Taniguchi, T ;
Fujita, T ;
Kanakura, Y ;
Komiya, S ;
Yoshimura, A .
NATURE, 1997, 387 (6636) :921-924